pubmed-article:10654648 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10654648 | lifeskim:mentions | umls-concept:C0041296 | lld:lifeskim |
pubmed-article:10654648 | lifeskim:mentions | umls-concept:C1522720 | lld:lifeskim |
pubmed-article:10654648 | lifeskim:mentions | umls-concept:C0080032 | lld:lifeskim |
pubmed-article:10654648 | lifeskim:mentions | umls-concept:C0009528 | lld:lifeskim |
pubmed-article:10654648 | lifeskim:mentions | umls-concept:C0596035 | lld:lifeskim |
pubmed-article:10654648 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:10654648 | pubmed:dateCreated | 2000-2-24 | lld:pubmed |
pubmed-article:10654648 | pubmed:abstractText | To determine whether measurement of the complement activation products SC5b-9 and C3a-desArg in pleural fluid can reliably differentiate tuberculous from malignant pleural effusions. | lld:pubmed |
pubmed-article:10654648 | pubmed:language | eng | lld:pubmed |
pubmed-article:10654648 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10654648 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10654648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10654648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10654648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10654648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10654648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10654648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10654648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10654648 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10654648 | pubmed:month | Jan | lld:pubmed |
pubmed-article:10654648 | pubmed:issn | 1027-3719 | lld:pubmed |
pubmed-article:10654648 | pubmed:author | pubmed-author:RubinLL | lld:pubmed |
pubmed-article:10654648 | pubmed:author | pubmed-author:VivesMM | lld:pubmed |
pubmed-article:10654648 | pubmed:author | pubmed-author:PérelLL | lld:pubmed |
pubmed-article:10654648 | pubmed:author | pubmed-author:PorcelJ MJM | lld:pubmed |
pubmed-article:10654648 | pubmed:author | pubmed-author:GázquezII | lld:pubmed |
pubmed-article:10654648 | pubmed:author | pubmed-author:Vicente de... | lld:pubmed |
pubmed-article:10654648 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10654648 | pubmed:volume | 4 | lld:pubmed |
pubmed-article:10654648 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10654648 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10654648 | pubmed:pagination | 76-82 | lld:pubmed |
pubmed-article:10654648 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:meshHeading | pubmed-meshheading:10654648... | lld:pubmed |
pubmed-article:10654648 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10654648 | pubmed:articleTitle | Usefulness of pleural complement activation products in differentiating tuberculosis and malignant effusions. | lld:pubmed |
pubmed-article:10654648 | pubmed:affiliation | Department of Internal Medicine, University Hospital Arnau de Vilanova, University of Lleida, Spain. | lld:pubmed |
pubmed-article:10654648 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10654648 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |